Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 31:39:101718.
doi: 10.1016/j.rmcr.2022.101718. eCollection 2022.

Management of life-threatening malignant central airway obstruction: A novel approach of using extracorporeal membrane oxygenation with tumor debulking and stenting

Affiliations
Case Reports

Management of life-threatening malignant central airway obstruction: A novel approach of using extracorporeal membrane oxygenation with tumor debulking and stenting

Nicole Clapp et al. Respir Med Case Rep. .

Abstract

Extracorporeal membrane oxygenation (ECMO) is an artificial lung or heart used to oxygenate and circulate blood. Veno-venous ECMO is most commonly used as an emergency therapy in patients with acute respiratory distress syndrome (ARDS), but it has the potential to be useful in other respiratory-related diseases. We report a case where ECMO successfully allowed for interventional pulmonary procedures in a patient with life-threatening tracheal obstruction secondary to lung cancer, requiring tumor debulking and silicone Y stent placement. The patient was a 44-year-old male who was admitted to the intensive care unit (ICU) for an advanced stage subcarinal tumor invading into the trachea and bilateral main stem bronchi. The tumor was unresectable, and the first attempt to debulk the tumor was terminated due to the risk of complete airway occlusion. With the help of ECMO, the second attempt at tumor debulking was successful, and a Y stent was placed. The patient regained ventilation in both lungs and was transferred out of the ICU on day 2 post-op. The pathology confirmed squamous cell carcinoma, programmed death-ligand 1 (PD-L1) 99%. The patient received immunotherapy after hospital discharge. ECMO has the potential to be useful for patients with severe tracheal obstructions and compromised respiratory systems. For patients with certain types of lung cancer, who are good candidates for novel immunotherapies and targeted therapies, it offers a potential bridging therapy for procedures that would otherwise be too dangerous and should be considered when traditional treatments for these patients fail.

Keywords: Extracorporeal membrane oxygenation (ECMO); Immunotherapy; Malignant central airway obstruction; Tracheobronchial stent.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest to disclose from the authors.

Figures

Fig. 1
Fig. 1
CT showed subcarinal tumor invading into the carina.
Fig. 2
Fig. 2
PET showed hypermetabolic subcarinal mass.
Fig. 3
Fig. 3
The flexible bronchoscopy showed the tumor right above the carina.
Fig. 4
Fig. 4
Tumor debulking with ECMO support.
Fig. 5
Fig. 5
Y stent was placed (trachea view).
Fig. 6
Fig. 6
Y stent was placed (carina view).

Similar articles

Cited by

References

    1. Reck M., et al. Five-year outcomes with pembrolizumab versus chemotherapy for metastatic non–small-cell lung cancer with PD-L1 tumor proportion score ≥ 50% J. Clin. Oncol. 2021;39(21):2339–2349. doi: 10.1200/jco.21.00174. - DOI - PMC - PubMed
    1. Shaheen A., et al. Veno-venous extracorporeal membrane oxygenation (V V ECMO): indications, preprocedural considerations, and technique. J. Card. Surg. 2016;31(4):248–252. doi: 10.1111/jocs.12690. - DOI - PubMed
    1. Mattiuzzi C., Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9(4):217–222. doi: 10.2991/jegh.k.191008.001. - DOI - PMC - PubMed
    1. Ruiz-Cordero R., Devine W.P. Targeted therapy and checkpoint immunotherapy in lung cancer. Surg Pathol Clin. 2020;13(1):17–33. doi: 10.1016/j.path.2019.11.002. - DOI - PubMed
    1. Oberg C., Folch E., Santacruz J.F. Management of malignant airway obstruction. AME Medical Journal. 2018;3 https://amj.amegroups.com/article/view/4747

Publication types